title: Diagnostics and treatment of the diabetic foot.
abstract: Every 30 s, a lower limb is amputated due to diabetes. Of all amputations in diabetic patients 85% are preceded by a foot ulcer which subsequently deteriorates to a severe infection or gangrene. There is a complexity of factors related to healing of foot ulcers including strategies for treatment of decreased perfusion, oedema, pain, infection, metabolic disturbances, malnutrition, non-weight bearing, wound treatment, foot surgery, and management of intercurrent disease. Patients with diabetic foot ulcer and decreased perfusion do often not have rest pain or claudication and as a consequence non-invasive vascular testing is recommended for early recognition of ulcers in need of revascularisation to achieve healing. A diabetic foot infection is a potentially limb-threatening condition. Infection is diagnosed by the presence or increased rate of signs inflammation. Often these signs are less marked than expected. Imaging studies can diagnose or better define deep, soft tissue purulent collections and are frequently needed to detect pathological findings in bone. The initial antimicrobial treatment as well as duration of treatment is empiric. There is a substantial delay in wound healing in diabetic foot ulcer which has been related to various abnormalities. Several new treatments related to these abnormalities have been explored in wound healing with various successes. An essential part of the strategy to achieve healing is an effective offloading. Many interventions with advanced wound management have failed due to not recognizing the need for effective offloading. A multidisciplinary approach to wounds and foot ulcer has been successfully implemented in different centres with a substantial decrease in amputation rate.
authors.affiliation: Department of Endocrinology, University Hospital of Skåne (SUS), 205 02, Malmö, Sweden. Jan.apelqvist@skane.se
authors.forename: Jan
authors.initials: J
authors.lastname: Apelqvist
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use; D017719:Diabetic Foot / Q000150:complications / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D003929:Diabetic Neuropathies / Q000503:physiopathology; D006801:Humans; D009894:Opportunistic Infections / Q000150:complications / Q000188:drug therapy; D010019:Osteomyelitis / Q000150:complications / Q000188:drug therapy; D018461:Soft Tissue Infections / Q000150:complications / Q000188:drug therapy; D014945:Wound Healing
chemical_list: D000890:Anti-Infective Agents